연구성과로 돌아가기

2024 연구성과별 연구자 정보 (646 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Hong, Kyung Soo Hong, KS 2 Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Choi, Sun Ha Choi, SH 3 Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Lee, Shin Yup Lee, SY 4 Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Shin, Kyeong-Cheol Shin, KC 5 Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Jang, Jong Geol Jang, JG 6 Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Kwon, Yong Shik Kwon, YS 7 Keimyung Univ, Sch Med, Dept Internal Med, Busan, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Park, Sun Hyo Park, SH 8 Keimyung Univ, Sch Med, Dept Internal Med, Busan, South Korea JVN-6216-2024 Park, Sun Hyo fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Choi, Keum-Ju Choi, KJ 9 Daegu Catholic Univ, Coll Med, Dept Internal Med, Daegu, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Jung, Chi Young Jung, CY 10 Daegu Catholic Univ, Coll Med, Dept Internal Med, Daegu, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Eom, Jung Seop Eom, JS 11 Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Kim, Saerom Kim, S 12 Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Seol, Hee Yun Seol, HY 13 Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Kim, Jehun Kim, J 14 Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Kim, Insu Kim, I 15 Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Park, Jin Han Park, JH 16 Inje Univ, Coll Med, Dept Internal Med, Busan, South Korea fireajh@gmail.com;
페이지 이동: